HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.
about
Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosisThe roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolismHIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis.Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux.Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan womenAssociation between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African womenAtherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast NigeriaInteraction of pathogens with host cholesterol metabolismHIV and HAART-Associated DyslipidemiaHuman immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular diseasePlasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAARTMetabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational studyImpact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation.Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in CambodiaPrevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in ChinaHigh prevalence of lipid abnormalities among antiretroviral-naive HIV-infected Asian children with mild-to-moderate immunosuppression.Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia.Toxic metabolic syndrome associated with HAART.Impact of age on markers of HIV-1 diseaseAssociation of immune recovery with hyperlipidaemia and apolipoprotein gene polymorphisms following highly active antiretroviral therapy in a cohort of Chinese HIV patients.HIV infection and high density lipoprotein metabolismAltered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.The role of HIV in serious diseases other than AIDS.Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES).Serum lipid and glucose profiles in HIV-positive Nigerian children.Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity.Evolution of lipid levels in HIV-infected children treated or not with HAART in Abidjan, Cote d'Ivoire.Alterations in lipid transfer to high-density lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients.Role of LCAT and Apo A-I in Newly Diagnosed HIV Patients.Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression.Insulin Resistance in HIV-Patients: Causes and ConsequencesFrom lipodystrophy to cardiovascular disease: new insight into the management of HIV infection
P2860
Q27004131-3632B15E-D450-45D1-8E5C-A7B33F2E53C8Q27021950-7C0A141A-0E15-4777-BE7D-C22037725FB0Q33775135-C45A75CE-D0B6-4F33-8291-548CB28D7748Q34101172-B9263DB1-1661-4700-BA94-68E6766FC51BQ34133465-D0223C91-FA88-49B6-97A7-21CB21D28468Q34138834-4016373E-367F-464C-A401-9C807A3773A8Q34228996-9BF05C81-28B1-498A-AB66-BDA118188D70Q34451471-8FD08F39-6FFF-4D80-A121-741DF86C19B6Q35020217-162E6DCA-D70B-4D2C-8367-6CF5DDA55234Q35104006-765EF65B-8D4C-435E-A67E-C523CEEF3B7FQ35120957-BC662763-D2D1-4894-A92C-A3FC7179868FQ35185674-75E7344A-A2FB-459F-B4EC-B32FFC7FFE14Q35567828-DC810205-7EA3-4355-8387-D5D5B490A944Q35625941-772A052F-1EE9-445A-A234-24F1837D4B1AQ36118338-7CEB1F2D-1993-48EB-AB44-8C8722AD42AAQ36359159-CEE823ED-5AB3-487F-9F52-6694105C9C5FQ36488227-6C8C6C58-5E4F-4F64-8A9D-013CF127180FQ36509994-5E4FE20B-6368-404E-8F35-3DD2D828FF32Q36544924-BFAF4743-59E8-4EEB-A6D9-39B869A3F6DCQ36763762-0460DC5F-80A5-493C-988C-2A4D9A937EADQ36819139-4D34BC1F-6955-4152-91EF-4C55C6C891BEQ36841647-7B6030F0-816B-46F5-A313-98118EFD7FDEQ36951647-2860A91A-E4E8-4C85-BCEC-27796A6B4E64Q37186467-DB0C3BB2-93C0-43A3-8D19-37E30AEADEC8Q37435125-C963DD1E-1A4F-44CF-B969-59A934D204B3Q40060225-54E811AB-453A-41C6-BE1D-C0EEFB9E1DC2Q42334793-54952115-F0B2-415A-A48B-85175D2811DEQ43060168-ABFEC963-9E97-4DA2-BE6D-FA4A4B16BBF3Q44355459-8C8B1AEE-EA3B-445E-A282-E5E0D3798DD9Q46350063-628333DC-7B53-4EBB-ABFA-9812BF8A7E5AQ47603224-B73AAE68-8DAA-4A0B-A514-92AE96F492F1Q51625767-3C4D1451-EFCB-4683-8B8E-6D5054DA416FQ55389479-8C269D76-6BC3-4DC5-AD5C-4A65886AAD18Q58763014-9D6DF53D-88AC-4AC6-9182-BC5382AFE9A1Q58798012-A4C0CDD6-7272-406A-B885-6D69D2E9AFDA
P2860
HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
HIV infection and high-density ...... se vs the effect of treatment.
@en
HIV infection and high-density ...... se vs the effect of treatment.
@nl
type
label
HIV infection and high-density ...... se vs the effect of treatment.
@en
HIV infection and high-density ...... se vs the effect of treatment.
@nl
prefLabel
HIV infection and high-density ...... se vs the effect of treatment.
@en
HIV infection and high-density ...... se vs the effect of treatment.
@nl
P2093
P50
P1433
P1476
HIV infection and high-density ...... ase vs the effect of treatment
@en
P2093
Anne Mijch
Bronwen Bryant
Dmitri Sviridov
Honor Rose
P356
10.1016/J.METABOL.2005.07.012
P577
2006-01-01T00:00:00Z